| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892; and
Cancer Vaccine Unit, Ludwig Institute for Cancer Research, Austin and Repatriation Medical Center, Heidelberg, Victoria, Australia
The extent to which naive CD8+ CTLs (TCD8+) are primed by APCs presenting endogenous Ags (direct priming) or Ags acquired from other infected cells (cross-priming) is a critical topic in basic and applied immunology. To examine the contribution of direct priming in the induction of VV-specific TCD8+, we generated recombinant vaccinia viruses that express human CMV proteins (US2 and US11) that induce the destruction of newly synthesized MHC class I molecules. Expression of US2 or US11 was associated with a 24–63% decrease in numbers of primary or secondary VV-specific TCD8+ responding to i.p. infection. Using HPLC-isolated peptides from VV-infected cells, we show that US2 and US11 selectively inhibit TCD8+ responses to a subset of immunogenic VV determinants. Moreover, VV-US2 and lysates from VV-infected histoincompatible cells elicit TCD8+ specific for a similar subset of VV determinants. These findings indicate that US2 and US11 can function in vivo to interfere with the activation of virus-specific TCD8+. Furthermore, they suggest that 1) both cross-priming and direct priming contribute significantly to the generation of VV-specific TCD8+, 2) the sets of immunogenic vaccinia virus determinants generated by cross-priming and direct priming are not completely overlapping, and 3) cross-priming overrides the effects of cis-acting viral interference with the class I Ag presentation pathway.
This article has been cited by other articles:
|
|
 |
|
  A. C. Jirmo, C.-H. Nagel, C. Bohnen, B. Sodeik, and G. M. N. Behrens Contribution of Direct and Cross-Presentation to CTL Immunity against Herpes Simplex Virus 1 J. Immunol., January 1, 2009; 182(1): 283 - 292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. A. Cockburn, S. Chakravarty, M. G. Overstreet, A. Garcia-Sastre, and F. Zavala Memory CD8+ T Cell Responses Expand When Antigen Presentation Overcomes T Cell Self-Regulation J. Immunol., January 1, 2008; 180(1): 64 - 71. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Gasteiger, W. Kastenmuller, R. Ljapoci, G. Sutter, and I. Drexler Cross-Priming of Cytotoxic T Cells Dictates Antigen Requisites for Modified Vaccinia Virus Ankara Vector Vaccines J. Virol., November 1, 2007; 81(21): 11925 - 11936. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Thilo, P. Berglund, S. E. Applequist, J. W. Yewdell, H.-G. Ljunggren, and A. Achour Dissection of the Interaction of the Human Cytomegalovirus-derived US2 Protein with Major Histocompatibility Complex Class I Molecules: PROMINENT ROLE OF A SINGLE ARGININE RESIDUE IN HUMAN LEUKOCYTE ANTIGEN-A2 J. Biol. Chem., March 31, 2006; 281(13): 8950 - 8957. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Basta, R. Stoessel, M. Basler, M. van den Broek, and M. Groettrup Cross-Presentation of the Long-Lived Lymphocytic Choriomeningitis Virus Nucleoprotein Does Not Require Neosynthesis and Is Enhanced via Heat Shock Proteins J. Immunol., July 15, 2005; 175(2): 796 - 805. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Tscharke, G. Karupiah, J. Zhou, T. Palmore, K. R. Irvine, S.M. M. Haeryfar, S. Williams, J. Sidney, A. Sette, J. R. Bennink, et al. Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines J. Exp. Med., January 3, 2005; 201(1): 95 - 104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. B. J. Wong, C. B. Buck, X. Shen, and R. F. Siliciano An Evaluation of Enforced Rapid Proteasomal Degradation as a Means of Enhancing Vaccine-Induced CTL Responses J. Immunol., September 1, 2004; 173(5): 3073 - 3083. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Storni and M. F. Bachmann Loading of MHC Class I and II Presentation Pathways by Exogenous Antigens: A Quantitative In Vivo Comparison J. Immunol., May 15, 2004; 172(10): 6129 - 6135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Barel, M. Ressing, N. Pizzato, D. van Leeuwen, P. Le Bouteiller, F. Lenfant, and E. J. H. J. Wiertz Human Cytomegalovirus-Encoded US2 Differentially Affects Surface Expression of MHC Class I Locus Products and Targets Membrane-Bound, but Not Soluble HLA-G1 for Degradation J. Immunol., December 15, 2003; 171(12): 6757 - 6765. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Ramirez and L. J. Sigal Macrophages and Dendritic Cells Use the Cytosolic Pathway to Rapidly Cross-Present Antigen from Live, Vaccinia-Infected Cells J. Immunol., December 15, 2002; 169(12): 6733 - 6742. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Shen, S. B. J. Wong, C. B. Buck, J. Zhang, and R. F. Siliciano Direct Priming and Cross-Priming Contribute Differentially to the Induction of CD8+ CTL Following Exposure to Vaccinia Virus Via Different Routes J. Immunol., October 15, 2002; 169(8): 4222 - 4229. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
